Outsourced Pharma Products & Services
-
Process Transfer CDMO Services
11/22/2019
Cytovance® has a 10+ year track record of successful technology transfer to support a wide range of biologics and clinical stages. Our core objective is to ensure that the contracted activities are well aligned with our clients’ objectives, whether they are focused on scale-up from early stage development phases to commercial manufacturing, expanding commercial scale to meet new market demand, or modifying the manufacturing process to improve process economics. Each customer project is customized to match the required scope and clinical phase. Commercial and in-house mammalian and microbial platform processes enable efficient movement through development programs and into commercialization.
-
High-Quality Capsule Production To Fit Your Needs
1/15/2026
Whether you have a requirement for clinical trial materials or commercial product, Mikart offers a variety of capsule options to fit your needs.
-
Protein Expression Technology CDMO Services
11/22/2019
Cytovance® has a dedicated group that focuses on Expression Technologies using both Mammalian and Microbial systems. We offer our partners access to our proprietary, IP-free, royalty-free E. coliexpression platform, the Keystone Expression System® and to the mammalian platform using Gibco® Freedom® CHO-S® Kit from Life Technologies, a Thermo Fisher Scientific brand. Proper alignment of strain/cell line development with bioprocess development ensures efficient execution of your program.
-
MAD7 Gene Editing
9/30/2025
A Class 2 Type V Cas9 nuclease, Mad7 is ideal for product development that relies on genome editing.
-
Dust Cups
3/16/2009
Natoli Dust Cups and Bellows are made with FDA-approved materials, and are selected to meet specific requirements for stability, wear-resistance, cleaning, and flexibility.
-
It All Starts With An Idea…Unlocking Pharmaceutical Success
7/30/2024
Every capsule and tablet begins with an idea. It takes a professional and innovative manufacturing partner to turn that idea into a reality. Enter Natoli, a name synonymous with excellence in pharmaceutical equipment and services. From the early stages of formulation to the grand scale of full-blown production, Natoli offers a seamless journey through every step of the process. Whether you’re unsure of how to start or how to finish, Natoli can guide the way.
-
Compaction Simulation / Emulation
7/30/2024
Building on the capabilities of the NP-RD10A benchtop tablet press (discussed in our previous article on USP <1062>), our services are further enhanced by the integration of the Presster™ compaction emulator. This state-of-the-art tool is designed to replicate the compaction dynamics of production tablet presses in a laboratory setting. It allows for tangible fine-tuning of the compression cycle, providing an accurate depiction of how a tablting formulation will behave under commercial manufacturing conditions. Using the Presster, Natoli Scientific can simulate full-scale production, permitting us to forecast problems before they escalate to costly production delays. Our experts can optimize the tablet design for our clients, ensuring a smooth transition from laboratory to production while adhering to the rigorous standards set by the industry including the current USP <1062> chapter.
-
Affinity Chromatography Resin For Purifying Recombinant Proteins
3/27/2024
An affinity chromatography resin for purifying recombinant proteins using the self-cleaving Cytiva™ Protein Select™ tag.
-
Powering Production Of Viral Vector-Based Therapies
11/14/2025
Gene therapies hold immense potential to provide long-lasting treatments for a wide range of diseases. At Cytiva, we offer GMP-compliant, end-to-end manufacturing solutions designed to support the development and commercialization of advanced medicines across multiple modalities – including AAV, adenovirus (AV), lentivirus (LV), plasmid DNA (pDNA) and exosomes. Our dependable suite of technologies and expertise ensures scalability, quality, and regulatory confidence at every stage of your journey.
-
Process Development: Mammalian, Bacteria And Yeast Based Success
2/17/2022
At AGC Biologics, we have developed over 200 mammalian, bacteria and yeast-based processes, giving us the insight necessary to identify and optimize process parameters that are critical for achieving a high-quality, cost-effective manufacturing process.